| Diabetes mellitus and electrolyte disorders G Liamis, E Liberopoulos, F Barkas, M Elisaf World Journal of Clinical Cases: WJCC 2 (10), 488, 2014 | 471 | 2014 |
| Spurious electrolyte disorders: a diagnostic challenge for clinicians G Liamis, E Liberopoulos, F Barkas, M Elisaf American journal of nephrology 38 (1), 50-57, 2013 | 140 | 2013 |
| Electrolyte and acid-base disorders in inflammatory bowel disease F Barkas, E Liberopoulos, A Kei, M Elisaf Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of …, 2013 | 89 | 2013 |
| Uric acid and incident chronic kidney disease in dyslipidemic individuals F Barkas, M Elisaf, E Liberopoulos, R Kalaitzidis, G Liamis Current medical research and opinion 34 (7), 1193-1199, 2018 | 67 | 2018 |
| Diet and cardiovascular disease risk among individuals with familial hypercholesterolemia: systematic review and meta-analysis F Barkas, T Nomikos, E Liberopoulos, D Panagiotakos Nutrients 12 (8), 2436, 2020 | 62 | 2020 |
| Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysis F Barkas, M Elisaf, H Milionis Atherosclerosis 243 (1), 60-64, 2015 | 52 | 2015 |
| Hyponatremia in acute stroke patients: pathophysiology, clinical significance, and management options G Liamis, F Barkas, E Megapanou, E Christopoulou, A Makri, K Makaritsis, ... European Neurology 82 (1-3), 32-40, 2020 | 51 | 2020 |
| Statin therapy with or without ezetimibe and the progression to diabetes F Barkas, M Elisaf, E Liberopoulos, E Klouras, G Liamis, EC Rizos Journal of Clinical Lipidology 10 (2), 306-313, 2016 | 51 | 2016 |
| Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: a systematic review and meta-analysis F Barkas, S Filippas-Ntekouan, M Kosmidou, E Liberopoulos, A Liontos, ... Rheumatology 60 (12), 5527-5537, 2021 | 47 | 2021 |
| Sinus bradycardia associated with remdesivir treatment in COVID-19: a case report and literature review F Barkas, CP Styla, A Bechlioulis, H Milionis, E Liberopoulos Journal of Cardiovascular Development and Disease 8 (2), 18, 2021 | 46 | 2021 |
| Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysis F Barkas, M Elisaf, V Tsimihodimos, H Milionis Diabetes & metabolism 43 (1), 1-8, 2017 | 43 | 2017 |
| Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019? F Barkas, H Milionis, G Anastasiou, E Liberopoulos Medical hypotheses 146, 110452, 2021 | 42 | 2021 |
| Protection against stroke with glucagon‐like peptide 1 receptor agonists: a systematic review and meta‐analysis F Barkas, M Elisaf, H Milionis European journal of neurology 26 (4), 559-565, 2019 | 40 | 2019 |
| Cholesteryl ester transfer protein inhibitors: challenges and perspectives TD Filippatos, E Klouras, F Barkas, M Elisaf Expert Review of Cardiovascular Therapy 14 (8), 953-962, 2016 | 38 | 2016 |
| How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic F Barkas, H Milionis, MS Kostapanos, DP Mikhailidis, M Elisaf, ... Current Medical Research and Opinion 31 (2), 221-228, 2015 | 38 | 2015 |
| Lipid target achievement among patients with very high and high cardiovascular risk in a lipid clinic F Barkas, EN Liberopoulos, MS Kostapanos, G Liamis, D Tziallas, ... Angiology 66 (4), 346-353, 2015 | 35 | 2015 |
| Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors to treat hypercholesterolemia: effect on stroke risk H Milionis, F Barkas, G Ntaios, V Papavasileiou, K Vemmos, P Michel, ... European journal of internal medicine 34, 54-57, 2016 | 30 | 2016 |
| The CHADS2 and CHA2DS2-VASc scores predict atrial fibrillation in dyslipidemic individuals: role of incorporating low high-density lipoprotein cholesterol levels F Barkas, M Elisaf, P Korantzopoulos, S Tsiara, E Liberopoulos International Journal of Cardiology 241, 194-199, 2017 | 28 | 2017 |
| High triglyceride levels alter the correlation of apolipoprotein B with low-and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome F Barkas, M Elisaf, E Liberopoulos, A Liontos, EC Rizos Atherosclerosis 247, 58-63, 2016 | 26 | 2016 |
| Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity F Barkas, M Elisaf, E Liberopoulos, G Liamis, EE Ntzani, EC Rizos Journal of cardiology 74 (3), 290-295, 2019 | 24 | 2019 |
Evangelos LiberopoulosNational and Kapodistrian University of Athens在 med.uoa.gr 的电子邮件经过验证
